Daptomycin in vitro susceptibility in European Gram-positive clinical isolates

International Journal of Antimicrobial Agents

Volumn 24, Issue 1, 2004, Pages 59-66

  Fluit, Ad C ^a   Schmitz, Franz Joseph ^a   Verhoef, Jan ^a   Milatovic, Dana ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibiotic resistance; Lipopeptide; Surveillance

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; GENTAMICIN; LINEZOLID; LIPOPEPTIDE; OXACILLIN; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; DRUG POTENCY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STREPTOCOCCUS PNEUMONIAE;

DAPTOMYCIN; ENTEROCOCCUS FAECALIS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 3042642523     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2003.12.014     Document Type: Article

References (16)

1. Fluit A.C., Wielders C.L.C., Verhoef J., Schmitz F.J. Epidemiology and susceptibility of 3, 051 Staphylococcus aureus isolates from 25 university hospitals participating in the European SENTRY study. J. Clin. Microbiol. 39:2001;3727-3732
2. Schouten M.A., Voss A., Hoogkamp-Korstanje J.A.A. Antimicrobial susceptibility patterns of enterococci causing infections in Europe. The European VRE Study Group. Antimicrob. Agents Chemother. 43:1999;2542-2546
3. Reinert R.R., Al-Lahham A., Lemperle M., et al. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J. Antimicrob. Chemother. 49:2002;61-68
4. Schmitz F.J., Verhoef J., Fluit A.C. Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European university hospitals. SENTRY Participants Group. Eur. J. Clin Microbiol. Infect. Dis. 18:1999;450-453
5. Wise R., Andrews J.M., Ashby J.P. Activity of daptomycin against Gram-positive pathogens: a comparison with other agents and the determination of a tentative breakpoint. J. Antimicrob. Chemother. 48:2001;563-567
6. Fuchs P.C., Barry A.L., Brown S.D. In vitro bactericidal activity of daptomycin against staphylococci. J. Antimicrob. Chemother. 49:2002;467-470
7. Barry A.L., Fuchs P.C., Brown S.D. In vitro activities of daptomycin against 2789 clinical isolates from 11 North American medical centers. Antimicrob. Agents Chemother. 45:2001;1919-1922
8. Silverman J.A., Oliver N., Andrew T., Li T. Resistance studies with daptomycin. Antimicrob. Agents Chemother. 45:2001;1799-1802
9. National Committee for Clinical Laboratory Standards (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 5th ed. Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
10. Thorne G.M., Alder J. Daptomycin: a novel lipopeptide antibiotic. Clin Microbiol. Newslett. 24:2002;33-40
11. Richter S.S., Kealy D.E., Murray C.T., Heilmann K.P., Coffman S.L., Doern G.V. The in vitro activity of daptomycin against Staphylococcus aureus and Enterococcus species. J. Antimicrob. Chemother. 52:2003;123-127
12. Critchley I.A., Draghi D.C., Sahm D.F., Thornsberry C., Jones M.E., Karlowsky J.A. Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001. J. Antimicrob. Chemother. 51:2003;639-649
13. Andrew J.H., Wale M.C., Wale L.J., Greenwood D. The effect of cultural conditions on the activity of LY146032 against staphylococci and streptococci. J. Antimicrob. Chemother. 20:1987;213-221
14. Louie A., Kaw P., Liu W., Jumbe N., Miller M.H., Drusano G.L. Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection. Antimicrob. Agents Chemother. 45:2001;845-851
15. Fuchs P.C., Barry A.L., Brown S.D. Evaluation of daptomycin susceptibility testing by Etest and the effect of different batches of media. J. Antimicrob. Chemother. 48:2001;557-561
16. Lakey J.H., Ptak M. Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY146032 and phospholipid membranes. Biochemistry. 27:1988;4639-4645